Management of invasive meningococcal disease in children and young people

 

Download the guideline

[arrow]

Full guideline
(section 4.1.2 updated
5 October 2010)

[Acrobat logo] (528K)
[arrow] Quick reference guide [Acrobat logo] (182K)
[arrow] Apple app
[arrow] Android app android badge small

[Guideline cover]REMIT OF THE GUIDELINE

This guideline makes recommendations on best practice in the recognition and management of meningococcal disease in children and young people up to 16 years of age. It addresses the patient journey through pre-hospital care, referral, diagnostic testing, disease management, follow-up care and rehabilitation and considers public health issues.

Guideline No. 102, ISBN 978 1 905813 31 5, May 2008

Patient information

Supporting material

[arrow] Press Release  
[arrow] Search strategy [Acrobat logo] (150K)
[arrow] Equality Impact Assessment [Acrobat logo] (51K)
[arrow] Register of Interest
A register of interest is not available for this guideline. In line with the SIGN Document Retention Schedule (24/07/2010), after publication of this guideline, hard copies of declarations of interest were held at the SIGN Executive offices for one year. The declarations of interest were then archived for a further three years before being destroyed along with other guideline related documents. This schedule has now been revised.
[arrow] Copyright Request form [Acrobat logo] (145K)
[arrow]

SIGN Guideline Survey

[Acrobat logo] (139K)

 

Related guidelines

Share with a colleague